U.S. Pharmaceuticals & Biotech Mid-Large Cap Stocks

Repligen

Market Cap: US$7.0b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

uniQure

Market Cap: US$3.2b

Develops treatments for patients suffering from rare and other devastating diseases in the United States.

IQVIA Holdings

Market Cap: US$30.8b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Rhythm Pharmaceuticals

Market Cap: US$6.4b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.

Roivant Sciences

Market Cap: US$10.0b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

Cytokinetics

Market Cap: US$5.8b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

Ligand Pharmaceuticals

Market Cap: US$3.3b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Bio-Rad Laboratories

Market Cap: US$7.5b

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

Jyong Biotech

Market Cap: US$4.3b

A science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia.

Celldex Therapeutics

Market Cap: US$1.7b

A biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.

Janux Therapeutics

Market Cap: US$1.4b

A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer.

Praxis Precision Medicines

Market Cap: US$1.0b

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.

Collegium Pharmaceutical

Market Cap: US$1.1b

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Liquidia

Market Cap: US$1.9b

A biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.

ANI Pharmaceuticals

Market Cap: US$1.9b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Prestige Consumer Healthcare

Market Cap: US$3.1b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

Summit Therapeutics

Market Cap: US$15.2b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Vertex Pharmaceuticals

Market Cap: US$96.6b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Harmony Biosciences Holdings

Market Cap: US$1.5b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

Viking Therapeutics

Market Cap: US$3.0b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Nektar Therapeutics

Market Cap: US$1.1b

A biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally.

Denali Therapeutics

Market Cap: US$2.0b

A biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases.

BridgeBio Pharma

Market Cap: US$9.7b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Novavax

Market Cap: US$1.4b

A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.

Ardelyx

Market Cap: US$1.5b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Krystal Biotech

Market Cap: US$4.7b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Teva Pharmaceutical Industries

Market Cap: US$22.1b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

BeOne Medicines

Market Cap: US$36.3b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

ICON

Market Cap: US$13.0b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

CureVac

Market Cap: US$1.2b

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Zymeworks

Market Cap: US$1.2b

A clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).

Metsera

Market Cap: US$5.5b

A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.

Cogent Biosciences

Market Cap: US$1.9b

A biotechnology company, focuses on developing precision therapies for genetically defined diseases.

Pharvaris

Market Cap: US$1.8b

A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.

Mirum Pharmaceuticals

Market Cap: US$3.7b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Amicus Therapeutics

Market Cap: US$2.6b

A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.